IMPLEMENT - Model Project for Quality-assured Exercise Therapy for Cancer Patients

Summary

IMPLEMENT aims to develop, test and establish a sustainable access structure for quality-assured oncological exercise therapy (qOET) in Germany as a model within the funding period of three years. This will be done in three phases:

Phase 1: In the first step, a characterization of the existing implementation structures and the existing barriers and needs as well as the establishment of the cooperation with the most important actors in the care system will take place.

Phase 2: In the subsequent implementation process, concrete measures are practically implemented in subprojects for specific target groups (children/adolescents, adults) and specific regions (rural, urban) as well as the digital solutions and interface management. With the help of a mixed-methods design, the barriers and facilitating factors of the implementation of area-wide qSBT will be investigated during the project and fed into a "learning system" for adaptation and improvement.

Phase 3: The success of the measures to increase patient participation in qOET and the development of the structures as well as the barrier and facilitating factors for an effective implementation will be addressed in a before-after comparison through evaluation steps and an economic accompanying evaluation will be carried out.

Conditions

• Cancer

Interventions

OTHER

Cancer Patients; Institutions and their employees in the treatment and/or counseling of cancer patients

The study population will be surveyed at 3 yearly measurement time points by means of questionnaires and interviews on attitudes, barrier and support factors for participation in exercise therapy.

Sponsors & Collaborators

• Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH

  collaborator OTHER

• University of Regensburg

  collaborator OTHER

• Ludwig-Maximilians - University of Munich

  collaborator OTHER

• Technical University of Munich

  collaborator OTHER

• Martin-Luther-Universität Halle-Wittenberg

  collaborator OTHER

• University Hospital Schleswig-Holstein

  collaborator OTHER

• Universitätsklinikum Hamburg-Eppendorf

  collaborator OTHER

• University Hospital, Essen

  collaborator OTHER

• University of Cologne

  lead OTHER

Principal Investigators

• Hajo Zeeb, Prof. Dr. · Leibniz Institute for Prevention Research and Epidemiology - BIPS GmbH

• Freerk Baumann, Prof. Dr. · University of Cologne

• Michael Leitzmann, Prof.Dr.Dr. · University of Regensburg

Study Design

Allocation

NA

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

5 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-09-01

Primary Completion

2025-11-30

Completion

2026-02-28

Countries

• Germany

Study Locations